Explore the words cloud of the CAST project. It provides you a very rough idea of what is the project "CAST" about.
The following table provides information about the project.
ACADEMISCH ZIEKENHUIS LEIDEN
|Coordinator Country||Netherlands [NL]|
|Total cost||4˙111˙553 €|
|EC max contribution||4˙111˙553 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2019-11-01 to 2023-10-31|
Take a look of project's partnership.
|1||ACADEMISCH ZIEKENHUIS LEIDEN||NL (LEIDEN)||coordinator||531˙239.00|
|2||THE UNIVERSITY OF LIVERPOOL||UK (LIVERPOOL)||participant||606˙345.00|
|3||EDINBURGH MOLECULAR IMAGING LIMITED||UK (EDINBURGH)||participant||303˙172.00|
|4||THE UNIVERSITY OF MANCHESTER||UK (MANCHESTER)||participant||303˙172.00|
|5||KAROLINSKA INSTITUTET||SE (STOCKHOLM)||participant||281˙982.00|
|6||SURGIMAB SAS||FR (MONTPELLIER)||participant||274˙802.00|
|7||UNIVERSITE DE STRASBOURG||FR (STRASBOURG)||participant||274˙802.00|
|8||PERCUROS BV||NL (LEIDEN)||participant||265˙619.00|
|9||STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS||NL (AMSTERDAM)||participant||265˙619.00|
|10||UNIVERSITA DEGLI STUDI DI CAMERINO||IT (CAMERINO)||participant||261˙499.00|
|11||SIMFO SPEZIELLE IMMUNOLOGIE FORSCHUNG UND ENTWICKLUNG GMBH||DE (BAYREUTH)||participant||252˙788.00|
|12||UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS||DE (GOETTINGEN)||participant||252˙788.00|
|13||FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD||PT (LISBOA)||participant||237˙720.00|
When a patient is discovered to have cancer, one of the primary goals is to have the tumour removed by surgery. Although this provides excellent oncological control, it is associated with morbidity and functional problems in cancer survivors. Recent studies have shown that the immediacy to perform a resection does not always lead to improved clinical outcome. Furthermore, cancer surgery can often lead to complications where the quality of life for the patient is compromised by toxic side effects and /or damage to nerves, organs or healthy tissues. A number of recent clinical trials in the field of cancer surgery have advocated the concept of watch and wait, watchful waiting, active monitoring or surveillance, which are terms used to describe a monitoring strategy for cancer. The concept may be antithetical but the functional advantage of these alternatives is clear even though there is some concern about the risk. Though the evidence is still weak, current studies suggest that with adequate selection and follow-up, this oncological risk is small. A major consideration for clinicians is now to maintain quality of life for all patients. Our objective in this proposal is to implement novel approaches so that cancer surgery can be avoided, where we aim to (a) develop new monitoring technologies from industry so that the surveillance window can be increased to allow for better treatment options over time and to avoid surgery, (b) develop new ‘watch and wait’ strategies in order to study the behaviour of the cancer so that any risks to the patient can be minimised leading to a better clinical outcome and (c) train a new generation of preclinical and clinical scientists to be able to implement this new concept as standard of care and to maximise the benefits of an active monitoring policy.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAST" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CAST" are provided by the European Opendata Portal: CORDIS opendata.